(Q22305810)

Dimensions

7 February 2023

2

Mark Jit

Mark

Jit

1 reference

Dimensions

7 February 2023

Anthony T. Newall

1

Anthony T.

Newall

1 reference

Dimensions

1006779288

Social contacts and mixing patterns relevant to the spread of infectious diseases

7 February 2023

language of work or name

English

0 references

publication date

August 2012

0 references

published in

PharmacoEconomics

0 references

volume

30

0 references

issue

8

0 references

page(s)

647-660

0 references

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Estimates of US influenza-associated deaths made using four different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Economic evidence of influenza vaccination in children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Herd protection against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

The Japanese experience with vaccinating schoolchildren against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Mortality benefits of influenza vaccination in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

The rational use of influenza vaccines in healthy children and children with underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Potential cost savings attributable to influenza vaccination of school-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Economic impact of influenza vaccination in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness study on influenza prevention in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost of influenza hospitalization at a tertiary care children's hospital and its impact on the cost-benefit analysis of the recommendation for universal influenza immunization in children age 6 to 23 months

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

An economic analysis of annual influenza vaccination of children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Population-wide benefits of routine vaccination of children against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Health benefits, risks, and cost-effectiveness of influenza vaccination of children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost Effectiveness of Influenza Vaccination in Older Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza: vaccination and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza vaccine effectiveness and confounding factors among young children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

New approaches to the assessment of vaccine herd protection in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Modelling the epidemiology of infectious diseases for decision analysis: a primer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Contingent valuation: what needs to be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

A comparison of scoring weights for the EuroQol derived from patients and the general public.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Modelling mitigation strategies for pandemic (H1N1) 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Estimating infectious disease parameters from data on social contacts and serological status

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Influenza-Associated Deaths among Children in the United States, 2003–2004

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Benefits And Costs Of Immunizing Children Against Influenza At School: An Economic Analysis Based On A Large-Cluster Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11599130-000000000-00000

Cost-effectiveness of influenza vaccination of healthy children

21 January 2018

1 reference

12 December 2020

Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra

1 reference

12 December 2020

Influenza vaccination

1 reference

12 December 2020

Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981

1 reference

12 December 2020

The protective effect of influenza vaccine in a mixed influenza A and B epidemic in a boys' boarding school

1 reference

12 December 2020

Seasonal influenza vaccination coverage among children aged 6 months-18 years --- eight immunization information system sentinel sites, United States, 2009-10 influenza season.

1 reference

12 December 2020

Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years

1 reference

12 December 2020

Community interventions and the epidemic prevention potential

1 reference

12 December 2020

Cost-Effectiveness of Adjuvanted Influenza Vaccination of Healthy Children 6 to 60 Months of Age

1 reference

12 December 2020

Theory versus practice: a review of 'willingness-to-pay' in health and health care

1 reference

12 December 2020

A study of influenza and influenza-related complications among children in a large US health insurance plan database

1 reference

12 December 2020

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

1 reference

12 December 2020

1 reference

12 December 2020

Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain

1 reference

12 December 2020

Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

1 reference

12 December 2020

National seasonal influenza vaccination survey in Europe, 2008.

1 reference

12 December 2020

Cost-effectiveness of influenza vaccination in high-risk children in Argentina

1 reference

12 December 2020

Estimating the impact of childhood influenza vaccination programmes in England and Wales

1 reference

12 December 2020

Vaccines for preventing influenza in healthy adults

1 reference

12 December 2020

Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections

1 reference

12 December 2020

Vaccines for preventing influenza in healthy children

1 reference

12 December 2020

Direct medical cost of influenza-related hospitalizations in children

1 reference

12 December 2020

10.2165/11599130-000000000-00000

Identifiers

DOI

0 references